1. Home
  2. NHTC vs NCEL Comparison

NHTC vs NCEL Comparison

Compare NHTC & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Health Trends Corp.

NHTC

Natural Health Trends Corp.

HOLD

Current Price

$1.77

Market Cap

22.1M

Sector

Miscellaneous

ML Signal

HOLD

NCEL

NewcelX Ltd. Ordinary Shares

SELL

Current Price

$3.76

Market Cap

22.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NHTC
NCEL
Founded
1988
2008
Country
United States
Switzerland
Employees
N/A
4
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.1M
22.0M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
NHTC
NCEL
Price
$1.77
$3.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.1K
33.2K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
13.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,776,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.55
$1.83
52 Week High
$5.10
$5.12

Technical Indicators

Market Signals
Indicator
NHTC
NCEL
Relative Strength Index (RSI) 39.39 46.33
Support Level $1.55 $2.58
Resistance Level $1.97 $3.70
Average True Range (ATR) 0.10 0.34
MACD 0.03 -0.06
Stochastic Oscillator 17.96 0.00

Price Performance

Historical Comparison
NHTC
NCEL

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and support active, physical, and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and the rest from China, Taiwan, Japan, the United States, and other regions.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.

Share on Social Networks: